Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXAM1E
|
||||
Drug Name |
4-{4-[3-(4-{[Benzyl-(3-methanesulfonylamino-2-methyl-phenyl)-amino]-methyl}-phenoxy)-phenoxy]-butyrylamino}-butyric acid
|
||||
Synonyms |
CHEMBL185265
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C36H41N3O7S
|
||||
Canonical SMILES |
Cc1c(NS(=O)(=O)C)cccc1N(Cc2ccccc2)Cc3ccc(Oc4cccc(OCCCC(=O)NCCCC(=O)O)c4)cc3
|
||||
InChI |
InChI=1S/C36H41N3O7S/c1-27-33(38-47(2,43)44)14-7-15-34(27)39(25-28-10-4-3-5-11-28)26-29-18-20-30(21-19-29)46-32-13-6-12-31(24-32)45-23-9-16-35(40)37-22-8-17-36(41)42/h3-7,10-15,18-21,24,38H,8-9,16-17,22-23,25-26H2,1-2H3,(H,37,40)(H,41,42)
|
||||
InChIKey |
KHLLMEXZTPDMCY-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Progesterone receptor | Target Info | [1587926] | ||
mRNA of androgen receptor | Target Info | [1587926] | |||
Pathway Interaction Database | Cellular roles of Anthrax toxinsmad2_3nuclearpathway:Regulation of nuclear SMAD2/3 signaling | ||||
Coregulation of Androgen receptor activity | |||||
Regulation of Androgen receptor activity | |||||
Nongenotropic Androgen signaling | |||||
Regulation of nuclear beta catenin signaling and target gene transcription | |||||
FOXA1 transcription factor network | |||||
Notch-mediated HES/HEY network | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.